Regulation of physiological and pathological Th1 and Th2 responses by lactoferrinThis paper is one of a selection of papers published in this Special Issue, entitled 7th International Conference on Lactoferrin: Structure, Function, and Applications, and has undergone the Journal's usual peer review process.
The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Abstract
In recent years, Lf has gained increasing interest as a result of its protective effects against a variety of diseases. While iron binding and interactions with mammalian receptors and microbial components are the best described mechanisms of action, recent studies have provided evidence that Lf properties may be related to immunoregulatory effects on Th1/Th2 cell activities. In vitro and in vivo experiments show that Lf is able to stimulate the differentiation of T cells from their immature precursors through the induction of the CD4 antigen. Studies performed under nonpathogenic conditions have shown distinct results with regard to the ability of Lf to support the proliferation and differentiation of Th cells into the Th1 or the Th2 phenotype. In addition, Lf plays different roles in diseases by affecting the Th1/Th2 cytokine balance in a manner dependent on the host’s immune status. Thus, Lf could cause a Th1 polarization in diseases in which the ability to control infection or tumor relies on a strong Th1 response. Lf may also reduce the Th1 component to limit excessive inflammatory responses. Finally, Lf may provide protection against Th1- or Th2-induced diseases, such as autoimmune or allergic diseases, through correction of the Th1/Th2 imbalance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activated Mø express and release lactoferrin, which scavenges and restricts Fe availability to extracellular pathogens [6,117,118] (Fig 2).Lactoferrin also protects Mø from oxidative stress [117,119] and modulates Mø microbicidal activity, as shown in the context of Staphylococcus aureus infection [120,121].”
From The Iron age of host–microbe interactions (2015) · cites this paper as [119]
Citations
Cites
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
Functional diversity of helper T lymphocytes
Abbas, A. K., Murphy, K. M., & Sher, A. (1996) · Nature · doi:10.1038/383787a0 · Cited by 4,450 · cited 1×
“On the other hand, Th2 cells produce a pattern of cytokines, including interleukin 4 (IL-4) and IL-5, that favors the generation of humoral responses (Paul and Seder 1994; Abbas et al. 1996).”
BackgroundLymphocyte responses and cytokines
Paul, W. E., & Seder, R. A. (1994) · Cell · doi:10.1016/0092-8674(94)90332-8 · Cited by 1,828 · cited 1×
“On the other hand, Th2 cells produce a pattern of cytokines, including interleukin 4 (IL-4) and IL-5, that favors the generation of humoral responses (Paul and Seder 1994; Abbas et al. 1996).”
BackgroundLymphokine Production by Human T Cells in Disease States
Romagnani, S. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.227 · Cited by 1,343 · cited 1×
“1986) and human (Romagnani 1994) CD4-positive T helper lymphocytes are classified into several subsets, according to the type of cytokines they secrete.”
BackgroundLactoferrin: a general review.
Levay, P., & Viljoen, M. (1995) · PubMed · Cited by 781
Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment
Yamauchi, K., Tomita, M., Giehl, T. J., & Ellison, R. T. (1993) · Infection and Immunity · doi:10.1128/iai.61.2.719-728.1993 · Cited by 500
The role of lymphocytes in allergic disease
Romagnani, S. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.104575 · Cited by 446 · cited 1×
“A number of diseases have been associated with exaggerated Th1 or Th2 responses: for example, allergies are regarded as Th2-mediated diseases, whereas autoimmune conditions, such as arthritis, are considered Th1-mediated diseases (Mauri et al. 1996; Romagnani 2000).”
BackgroundLactoferrin: Multifunctional roles of lactoferrin: a critical overview
Ward, P. P., Paz, E., & Conneely, O. M. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5369-8 · Cited by 443 · cited 1×
“The pleiotropic activities of Lf have been linked to several distinct mechanisms, the best described consisting of iron binding and interactions with mammalian receptors and microbial components (Ward et al. 2005).”
BackgroundFecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation
Kane, S. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00232-6 · Cited by 364 · cited 1×
“1999), and in stool samples from patients with ulcerative colitis, Crohn’s disease, or irritable bowel syndrome (Sugi et al. 1996; Dwarakanath et al. 1997; Kane et al. 2003; Buderus et al. 2004).”
BackgroundLactoferrin is a lipid A-binding protein
Appelmelk, B. J., An, Y. Q., Geerts, M., Thijs, B. G., de Boer, H. A., MacLaren, D. M., de Graaff, J., & Nuijens, J. H. (1994) · Infection and Immunity · doi:10.1128/iai.62.6.2628-2632.1994 · Cited by 362 · cited 1×
“Lf has been shown to bind lipid A moiety of LPS (Appelmelk et al. 1994; Elass-Rochard et al. 1995), inhibiting subsequent binding to CD14 receptors on macrophages (Elass-Rochard et al.”
BackgroundLactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-κB
Håversen, L., Ohlsson, B. G., Hahn-Zoric, M., Hanson, L. Å., & Mattsby-Baltzer, I. (2002) · Cellular Immunology · doi:10.1016/s0008-8749(03)00006-6 · Cited by 336
Mauri, C., Williams, R. O., Walmsley, M., & Feldmann, M. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260716 · Cited by 307 · cited 1×
“A number of diseases have been associated with exaggerated Th1 or Th2 responses: for example, allergies are regarded as Th2-mediated diseases, whereas autoimmune conditions, such as arthritis, are considered Th1-mediated diseases (Mauri et al. 1996; Romagnani 2000).”
BackgroundRegulation of cytokine release from mononuclear cells by the iron- binding protein lactoferrin
Crouch, S., Slater, K., & Fletcher, J. (1992) · Blood · doi:10.1182/blood.v80.1.235.235 · Cited by 294
Elass-Rochard, E., Roseanu, A., Legrand, D., Trif, M., Salmon, V, Motas, C., Montreuil, J., & Spik, G. (1995) · Biochemical Journal · doi:10.1042/bj3120839 · Cited by 251
Bezault, J., Bhimani, R. S., Wiprovnick, J., & Furmanski, P. (1994) · PubMed · Cited by 205
Elass-Rochard, E., Legrand, D., Salmon, V., Roseanu, A., Trif, M., Tobias, P. S., Mazurier, J., & Spik, G. (1998) · Infection and Immunity · doi:10.1128/iai.66.2.486-491.1998 · Cited by 193 · cited 1×
“1995), inhibiting subsequent binding to CD14 receptors on macrophages (Elass-Rochard et al. 1998) and release of proinflammatory cytokines.”
BackgroundSugi, K., Saitoh, O., Hirata, I., & Katsu, K. (1996) · PubMed · Cited by 172
Zagulski, T., Lipiński, P., Zagulska, A., Broniek, S., & Jarzabek, Z. (1989) · PubMed Central · Cited by 162
Thompson, A. B., Bohling, T., Payvandi, F., & Rennard, S. I. (1990) · PubMed · Cited by 149
KRUZEL, M. L., HARARI, Y., MAILMAN, D., ACTOR, J. K., & ZIMECKI, M. (2002) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2002.01956.x · Cited by 138 · cited 1×
“The finding that Lf delivered as a prophylactic, concurrent, or therapeutic treatment differentially regulates pro- and anti-inflammatory cytokines during LPS-induced endotoxemia (Kruzel et al. 2002) also suggests that its mode of action is broader than a mere interaction with the LPS molecule or the CD14 antigen.”
BackgroundActivation of Intestinal Mucosal Immunity in Tumor‐bearing Mice by Lactoferrin
Wang, W., Iigo, M., Sato, J., Sekine, K., Adachi, I., & Tsuda, H. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb00880.x · Cited by 137
Lactoferrin Inhibits Hepatitis C Virus Viremia in Patients with Chronic Hepatitis C: A Pilot Study
Tanaka, K., Ikeda, M., Nozaki, A., Kato, N., Tsuda, H., Saito, S., & Sekihara, H. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00756.x · Cited by 136 · cited 1×
“2001) and inhibited hepatitis C virus viremia in patients with chronic hepatitis C (Tanaka et al. 1999; Iwasa et al. 2002).”
BackgroundInhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice
Iigo, M., Kuhara, T., Ushida, Y., Sekine, K., Moore, M. A., & Tsuda, H. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1026452110786 · Cited by 134 · cited 1×
“In other animal models of disease, oral (Iigo et al. 1999) or subcutaneous (Bezault et al.”
BackgroundBovine lactoferrin induces both mucosal and systemic immune response in mice
DEBBABI, H., DUBARRY, M., RAUTUREAU, M., & TOMÉ, D. (1998) · Journal of Dairy Research · doi:10.1017/s0022029997002732 · Cited by 133
Self-citationTOGAWA, J., NAGASE, H., TANAKA, K., INAMORI, M., NAKAJIMA, A., UENO, N., SAITO, T., & SEKIHARA, H. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2002.02868.x · Cited by 133
Kuhara, T., Iigo, M., Itoh, T., Ushida, Y., Sekine, K., Terada, N., Okamura, H., & Tsuda, H. (2000) · Nutrition and Cancer · doi:10.1207/s15327914nc382_8 · Cited by 130 · cited 2×
“For example, the antimetastatic activity of orally administered bLf has been associated with activation of mucosal immunity leading to enhanced production of IFN-g and IL-18 in the lamina propria of tumor-bearing mice (Kuhara et al. 2000; Wang et al. 2000).”
BackgroundImmunostimulatory activity of lactotransferrin and maturation of CD4− CD8− murine thymocytes
Zimecki, M., Mazurier, J., Machnicki, M., Wieczorek, Z., Montreuil, J., & Spik, G. (1991) · Immunology Letters · doi:10.1016/0165-2478(91)90099-v · Cited by 125 · cited 1×
“For instance, CD4 and CD8 double negative thymocytes acquired the CD4 antigen characteristic of Th lymphocytes following overnight incubation with Lf (Zimecki et al. 1991).”
BackgroundHåversen, L. A., Engberg, I., Baltzer, L., Dolphin, G., Hanson, L. Å., & Mattsby-Baltzer, I. (2000) · Infection and Immunity · doi:10.1128/iai.68.10.5816-5823.2000 · Cited by 121 · cited 2×
“2004), and bacterial (Zagulski et al. 1989; Teraguchi et al. 1995; Bhimani et al. 1999; Wada et al. 1999; Haversen et al. 2000; Kruzel et al. 2000) infections.”
BackgroundInfluence of lactoferrin feeding and injection against systemic staphylococcal infections in mice
Bhimani, R. S., Vendrov, Y., & Furmanski, P. (1999) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.1999.00644.x · Cited by 116
Oral Lactoferrin Treatment of Experimental Oral Candidiasis in Mice
Takakura, N., Wakabayashi, H., Ishibashi, H., Teraguchi, S., Tamura, Y., Yamaguchi, H., & Abe, S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2619-2623.2003 · Cited by 114 · cited 1×
“Lf administration leads to elimination of pathogens and contributes to the resolution of symptoms in several animal models of fungal (Wakabayashi et al. 2000; Yamauchi et al. 2000; Takakura et al. 2003), viral (Murphy et al.”
BackgroundLima, M. F., & Kierszenbaum, F. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.6.4176 · Cited by 111
Lactoferrin, a Potent Tryptase Inhibitor, Abolishes Late-Phase Airway Responses in Allergic Sheep
ELROD, K. C., MOORE, W. R., ABRAHAM, W. M., & TANAKA, R. D. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.2.9607012 · Cited by 109
Lactoferrin Protects Gut Mucosal Integrity During Endotoxemia Induced by Lipopolysaccharide in Mice
Kruzel, M. L., Harari, Y., Chen, C.-Y., & Castro, G. A. (2000) · Inflammation · doi:10.1023/a:1006935908960 · Cited by 107 · cited 1×
“2004), and bacterial (Zagulski et al. 1989; Teraguchi et al. 1995; Bhimani et al. 1999; Wada et al. 1999; Haversen et al. 2000; Kruzel et al. 2000) infections.”
Togawa, J.-I., Nagase, H., Tanaka, K., Inamori, M., Umezawa, T., Nakajima, A., Naito, M., Sato, S., Saito, T., & Sekihara, H. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00331.2001 · Cited by 106
Dhennin-Duthille, I., Masson, M., Damiens, E., Fillebeen, C., Spik, G., & Mazurier, J. (2000) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20001215)79:4<583::aid-jcb70>3.0.co;2-9 · Cited by 105
Enhanced Th1 Response to Staphylococcus aureus Infection in Human Lactoferrin-Transgenic Mice
Guillén, C., McInnes, I. B., Vaughan, D. M., Kommajosyula, S., Van Berkel, P. H. C., Leung, B. P., Aguila, A., & Brock, J. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.8.3950 · Cited by 100 · cited 1×
“Thus, Lf-transgenic mice displayed enhanced Th1 polarization of the cellmediated immune response, and this was associated with increased ability to clear Staphylococcus aureus infection (Guillen et al. 2002).”
BackgroundBoyaka, P. N., Sfeir, R. M., Dubarry, M., Rautureau, M., & Tomé, D. (2004) · Journal of Nutrition · doi:10.1093/jn/134.2.403 · Cited by 100 · cited 2×
“However, these effects were dependent on the mode of delivery (Sfeir et al. 2004).”
BackgroundSelf-citationUptake of ingested bovine lactoferrin and its accumulation in adult mouse tissues
Fischer, R., Debbabi, H., Blais, A., Dubarry, M., Rautureau, M., Boyaka, P. N., & Tomé, D. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2007.05.019 · Cited by 96
Self-citationUCHIDA, K., Matsuse, R., Tomita, S., Sugi, K., Saitoh, O., & Ohshiba, S. (1994) · Clinical Biochemistry · doi:10.1016/0009-9120(94)90027-2 · Cited by 84 · cited 1×
“Other conditions, including cancer (Uchida et al. 1994) and skin responses to an allergen (Zweiman et al.”
BackgroundAnti‐Inflammatory Activities of Human Lactoferrin in Acute Dextran Sulphate‐Induced Colitis in Mice
Håversen, L. A., Baltzer, L., Dolphin, G., Hanson, L. Å., & Mattsby‐Baltzer, I. (2003) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2003.01162.x · Cited by 81 · cited 1×
“1998) or colitis induced by dextran sulphate (Haversen et al. 2003).”
BackgroundFecal Lactoferrin: A New Parameter to Monitor Infliximab Therapy
Buderus, S., Boone, J. H., Lyerly, D. M., & Lentze, M. J. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000034568.69407.47 · Cited by 81
Regulation of epidermal Langerhans cell migration by lactoferrin
Cumberbatch, M., Dearman, R. J., Uribe‐luna, S., Headon, D. R., Ward, P. P., Conneely, O. M., & Kimber, I. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00014.x · Cited by 80
Epidermal Langerhans cell migration and sensitisation to chemical allergens
CUMBERBATCH, M., DEARMAN, R. J., GRIFFITHS, C. E. M., & KIMBER, I. (2003) · APMIS · doi:10.1034/j.1600-0463.2003.11107811.x · Cited by 77
Guillen, C., McInnes, I. B., Vaughan, D., Speekenbrink, A. B. J., & Brock, J. H. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200009)43:9<2073::aid-anr19>3.0.co;2-u · Cited by 76 · cited 1×
“Local injection of Lf was reported to decrease the severity of collagen-induced arthritis (Guillen et al. 2000), and oral treatment protected against carrageenan-induced inflammation (Zimecki et al.”
BackgroundLactoferrin given in food facilitates dermatophytosis cure in guinea pig models
Wakabayashi, H., Uchida, K., Yamauchi, K., Teraguchi, S., Hayasawa, H., & YAMAGUCHI, H. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.4.595 · Cited by 75 · cited 2×
“Indeed, Lf can exert its effects in tissues distant from the gastrointestinal tract, as demonstrated in several infectious animal models in which Lf is given orally (Bhimani et al. 1999; Haversen et al. 2000; Wakabayashi et al. 2000).”
BackgroundEffects of purified bovine whey factors on cellular immune functions in ruminants
Wong, C. W., Seow, H. F., Husband, A. J., Regester, G. O., & Watson, D. L. (1997) · Veterinary Immunology and Immunopathology · doi:10.1016/s0165-2427(96)05732-7 · Cited by 73 · cited 1×
“In another study (Wong et al. 1997), Lf inhibited proliferation of and IFN-g production by ovine blood lymphocytes in response to mitogenic stimulation.”
BackgroundGriffiths, C. E. M., Cumberbatch, M., Tucker, S. C., Dearman, R. J., Andrew, S., Headon, D. R., & Kimber, I. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04125.x · Cited by 72 · cited 1×
“In humans, Lf treatment reduced the clinical severity of contact allergy (Griffiths et al. 2001) and inhibited hepatitis C virus viremia in patients with chronic hepatitis C (Tanaka et al.”
BackgroundLong-term follow-up of chronic hepatitis C patients treated with oral lactoferrin for 12 months
Ishii, K. (2003) · Hepatology Research · doi:10.1016/s1386-6346(02)00279-6 · Cited by 71 · cited 1×
“the portal system and increases levels of Th1 cells in association with clearance of HCV (Ishii et al. 2003).”
BackgroundSmith, S. R., Calzetta, A., Bankowski, J., Kenworthy-Bott, L., & Terminelli, C. (1993) · Journal of Leukocyte Biology · doi:10.1002/jlb.54.1.23 · Cited by 67 · cited 2×
“However, IFN-g may be a mediator of endotoxic shock (Smith et al. 1993), and animal models of disease show that cytokines other than those secreted by macrophages are modulated by Lf during septicemia.”
BackgroundIwasa, M., Kaito, M., Ikoma, J., Takeo, M., Imoto, I., Adachi, Y., Yamauchi, K., Koizumi, R., & Teraguchi, S. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05573.x · Cited by 66
Lactoferrin: influences on Langerhans cells, epidermal cytokines, and cutaneous inflammation
Kimber, I., Cumberbatch, M., Dearman, R. J., Headon, D. R., Bhushan, M., & Griffiths, C. E. (2002) · Biochemistry and Cell Biology · doi:10.1139/o01-227 · Cited by 65 · cited 1×
“In a model of allergen cutaneous inflammation (Cumberbatch et al. 2000, 2003; Kimber et al. 2002), Lf directly inhibited IL-1b and TNF-a release by keratinocytes, the migration of allergen-primed Langerhans cells to lymph nodes, and lymphocyte priming.”
MethodWAKABAYASHI, H., KUROKAWA, M., SHIN, K., TERAGUCHI, S., TAMURA, Y., & SHIRAKI, K. (2004) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.68.537 · Cited by 64 · cited 1×
“Oral administration of Lf increased the splenocyte production of Th1-type cytokines (IFN-g and IL-12) in response to HSV type 1 infection (Wakabayashi et al. 2004).”
BackgroundThe Therapeutic Effect of Bovine Lactoferrin in the Host Infected with Helicobacter pylori
T. Wada, Y. A. (1999) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365529950173627 · Cited by 63 · cited 1×
“2004), and bacterial (Zagulski et al. 1989; Teraguchi et al. 1995; Bhimani et al. 1999; Wada et al. 1999; Haversen et al. 2000; Kruzel et al. 2000) infections.”
Takakura, N., Wakabayashi, H., Ishibashi, H., Yamauchi, K., Teraguchi, S., Tamura, Y., Yamaguchi, H., & Abe, S. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05505-0 · Cited by 60 · cited 1×
“Furthermore, in another model of fungal disease, the alleviation of candidiasis by Lf feeding correlated with increased production of IFN-g and tumor necrosis factor alpha (TNF-a) by cervical lymph node cells (Takakura et al. 2004).”
BackgroundMoed, H. D., Boorsma, D. M., Stoof, T. J., Blomberg, B. M. E. V., Bruynzeel, D. P., Scheper, R. J., Gibbs, S., & Rustemeyer, T. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.05975.x · Cited by 59 · cited 1×
“In a model of contact allergy mediated by both Th1 and Th2 cells, Lf inhibited T cell proliferation and the production of both Th1 and Th2 cytokines (Moed et al. 2004).”
BackgroundOrally administered bovine lactoferrin inhibits bacterial translocation in mice fed bovine milk
Teraguchi, S., Shin, K., Ogata, T., Kingaku, M., Kaino, A., Miyauchi, H., Fukuwatari, Y., & Shimamura, S. (1995) · Applied and Environmental Microbiology · doi:10.1128/aem.61.11.4131-4134.1995 · Cited by 58 · cited 1×
“2004), and bacterial (Zagulski et al. 1989; Teraguchi et al. 1995; Bhimani et al. 1999; Wada et al. 1999; Haversen et al. 2000; Kruzel et al. 2000) infections.”
Lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytes
Hwang, S., Wilk, K., Bangale, Y. A., Kruzel, M. L., & Actor, J. K. (2007) · Medical Microbiology and Immunology · doi:10.1007/s00430-007-0041-6 · Cited by 58
The Detection of Bovine Lactoferrin Binding Protein on Trypanosoma brucei
Tanaka, T., Abe, Y., Inoue, N., Kim, W., Kumura, H., Nagasawa, H., Igarashi, I., & Shimazaki, K. (2004) · Journal of Veterinary Medical Science · doi:10.1292/jvms.66.619 · Cited by 57 · cited 1×
“2001), parasitic (Tanaka et al. 2004), and bacterial (Zagulski et al.”
BackgroundMurphy, M. E., Kariwa, H., Mizutani, T., Tanabe, H., Yoshimatsu, K., Arikawa, J., & Takashima, I. (2001) · Journal of Veterinary Medical Science · doi:10.1292/jvms.63.637 · Cited by 57 · cited 1×
“2003), viral (Murphy et al. 2001), parasitic (Tanaka et al.”
The endogenous mediator of endotoxic shock.
Beutler, B., & Cerami, A. (1987) · PubMed · Cited by 57
Wakabayashi, H., Takakura, N., Teraguchi, S., & Tamura, Y. (2003) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2003.tb02783.x · Cited by 55 · cited 1×
“The reported increased levels of IFN-g and IL-12 in the peritoneal fluid of mice injected with inactivated Candida albicans enhanced macrophage activity (Wakabayashi et al. 2003).”
BackgroundHe, S., McEuen, A. R., Blewett, S. A., Li, P., Buckley, M. G., Leufkens, P., & Walls, A. F. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01651-9 · Cited by 55 · cited 1×
“As far as Th2-mediated atopic diseases are concerned, the protective role of Lf has been related to its ability to destabilize tryptase released from mast cells (Elrod et al. 1997; He et al. 2003).”
BackgroundCaccavo, D., Sebastiani, G. D., Monaco, C. D., Guido, F., Galeazzi, M., Ferri, G. M., Bonomo, L., & Afeltra, A. (1999) · International Journal of Clinical & Laboratory Research · doi:10.1007/s005990050059 · Cited by 51
Yamauchi, Hiruma, Yamazaki, Wakabayashi, Kuwata, Teraguchi, Hayasawa, Suegara, & Yamaguchi (2000) · Mycoses · doi:10.1046/j.1439-0507.2000.00571.x · Cited by 51
Richie, E. R., Hilliard, J. K., Gilmore, R. D., & Gillespie, D. J. (1987) · Journal of Reproductive Immunology · doi:10.1016/0165-0378(87)90041-6 · Cited by 50 · cited 1×
“For instance, mitogen- and alloantigen-induced (Richie et al. 1987) or concanavalin A-induced (Ashorn et al.”
BackgroundLactoferrin and secretory IgA in the bronchoalveolar lavage fluid from patients with a stable asthma
van de Graaf, E. A., Out, T. A., Kobesen, A., & Jansen, H. M. (1991) · Lung · doi:10.1007/bf02714163 · Cited by 49
Penco, S., Pastorino, S., Bianchi-Scarrà, G., & Garrè, C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.20.12263 · Cited by 46 · cited 1×
“Lf has also directs effects on macrophages through binding to specific receptors (Birgens 1994) and transcriptional regulation of gene expression (Penco et al. 1995; Haversen et al. 2002).”
BackgroundBi, B., Lefebvre, A. M., Duś, D., Spik, G., & Mazurier, J. (1997) · PubMed · Cited by 46
Release of lactoferrin and elastase in human allergic skin reactions.
Zweiman, B., Kucich, U., Shalit, M., Von Allmen, C., Moskovitz, A., Weinbaum, G., & Atkins, P. C. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.10.3953 · Cited by 44 · cited 1×
“1994) and skin responses to an allergen (Zweiman et al. 1990), have been associated with increased LF levels.”
BackgroundLactoferrin derived from neutrophils inhibits the mixed lymphocyte reaction
Slater, K., & Fletcher, J. (1987) · Blood · doi:10.1182/blood.v69.5.1328.1328 · Cited by 43 · cited 1×
“showed that Lf inhibited proliferation in mixed lymphocyte cultures (Slater and Fletcher 1987) and further demonstrated that this effect was due to inhibition of IL-2 production (Crouch et al.”
BackgroundGutteberg, T. J., Røkke, O., Andersen, O., & Jørgensen, T. (1989) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548909021701 · Cited by 41 · cited 1×
“The mechanisms underlying the antimicrobial properties of Lf are believed to include the deprivation of iron essential for microbe growth (Gutteberg et al. 1989), the destabilization of the microbe cell wall (Yamauchi et al.”
BackgroundLactoferrin inhibits proliferative response and cytokine production of TH1 but not TH2 cell lines.
Zimecki, M., Mazurier, J., Spik, G., & Kapp, J. A. (1996) · PubMed · Cited by 39
Antibacterial System Generated by Lactoferrin in Mice in vivo is Primarily a Killing System
(1998) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.1998.00058.x · Cited by 31 · cited 1×
“1993), and an increased phagocytosis (Lima and Kierszenbaum 1985; Zagulski et al. 1998).”
Wakabayashi, H., Takakura, N., Yamauchi, K., Teraguchi, S., Uchida, K., Yamaguchi, H., & Tamura, Y. (2002) · Journal of Medical Microbiology · doi:10.1099/0022-1317-51-10-844 · Cited by 30 · cited 1×
“(Wakabayashi et al. 2002) demonstrates that Lf could enhance the ability of Th cells to assist the fungicidal actions of macrophages.”
BackgroundZimecki, M., Międzybrodzki, R., & Szymaniec, S. (1998) · PubMed · Cited by 28
Expression of pulmonary lactoferrin in sudden-onset and slow-onset asthma with fatal outcome
Tsokos, M., & Paulsen, F. P. (2002) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-002-0666-1 · Cited by 23 · cited 1×
“1990) or asthma (van de Graaf et al. 1991; Tsokos and Paulsen 2002), in synovial fluid from patients with arthritis (Caccavo et al.”
BackgroundDwarakanath, A. D., Finnie, I. A., Beesley, C., O'Dowd, G., Nash, J., Tsai, H. H., Parker, N., & Rhodes, J. M. (1997) · Clinical Science · doi:10.1042/cs0920307 · Cited by 23 · cited 1×
“1999), and in stool samples from patients with ulcerative colitis, Crohn’s disease, or irritable bowel syndrome (Sugi et al. 1996; Dwarakanath et al. 1997; Kane et al. 2003; Buderus et al. 2004).”
BackgroundLactoferrin ameliorates symptoms of experimental encephalomyelitis in Lewis rats
Zimecki, M., Kocięba, M., Chodaczek, G., Houszka, M., & Kruzel, M. L. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.10.008 · Cited by 22
Ashorn, R., Eskola, J., Tuohimaa, P., & Krohn, K. J. E. (1986) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a136371 · Cited by 22
The Monocytic Receptor for Lactoferrin and its Involvement in Lactoferrin-Mediated Iron Transport
Birgens, H. (1994) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-2548-6_10 · Cited by 18
Van Der Velden, W. J. F. M., Blijlevens, N. M. A., & Donnelly, J. P. (2008) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2007.00260.x · Cited by 18
Zimecki, M., Stepniak, D. T., Szynol, A., & Kruzel, M. L. (2001) · PubMed · Cited by 18
Zimecki, M., Chodaczek, G., Kocięba, M., & Kruzel, M. L. (2004) · FEMS Immunology & Medical Microbiology · doi:10.1016/j.femsim.2004.04.003 · Cited by 13 · cited 1×
“Interestingly, there is a lack of protective action of Lf against endotoxemia in C3H/HeCr mice, presenting a defect in Th1 cytokine production, including IFN-g, in response to LPS (Zimecki et al. 2004).”
Background
Research works printed but not linked: 12
- Beutler B., 1987, Clin. Res., 35, 192
- Bezault J., 1994, Cancer Res., 54, 2310
- Bi B.Y., 1997, Arch. Immunol. Ther. Exp. (Warsz.), 45, 315
- 10.1111/j.1572-0241.2003.07458.x · doi:10.1111/j.1572-0241.2003.07458.x · Paper page
- Levay P.F., 1995, Haematologica, 80, 252
- 10.1146/annurev.iy.12.040194.001303 · DOI · Paper page
- Sugi K., 1996, Am. J. Gastroenterol., 91, 927
- Thompson A.B., 1990, J. Lab. Clin. Med., 115, 148
- Zagulski T., 1989, Br. J. Exp. Pathol., 70, 697
- Zimecki M., 1996, Arch. Immunol. Ther. Exp. (Warsz.), 44, 51
- Zimecki M., 1998, Arch. Immunol. Ther. Exp. (Warsz.), 46, 361
- Zimecki M., 2001, Arch. Immunol. Ther. Exp. (Warsz.), 49, 147
Cited by
Lactoferrin as a natural immune modulator
Actor, J., Hwang, S.-A., & Kruzel, M. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788453202 · Cited by 455
“In a Toxoplasma gondii infection model, oral lactoferrin favored a TH2 response in the gut mucosa, observed by a decrease in IFN-γ and elevation in IL-10 (a TH2 associated cytokine) [161].”
BackgroundOverview of Lactoferrin as a Natural Immune Modulator
Legrand, D. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.02.071 · Cited by 296
Lactoferrin Structure and Functions
Legrand, D., Pierce, A., Elass, E., Carpentier, M., Mariller, C., & Mazurier, J. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-74087-4_6 · Cited by 293
Habib, H. M., Ibrahim, S., Zaim, A., & Ibrahim, W. H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111228 · Cited by 250
The Iron age of host–microbe interactions
Soares, M. P., & Weiss, G. (2015) · The EMBO Reports · doi:10.15252/embr.201540558 · Cited by 227
“Lactoferrin also protects Mø from oxidative stress [117,119] and modulates Mø microbicidal activity, as shown in the context of Staphylococcus aureus infection [120,121].”
Metadata
- Authors
- Fischer, R., Debbabi, H., Dubarry, M., Boyaka, P., & Tomé, D.
- Affiliations
- University of Alabama at Birmingham (US)
- Venue
- Biochemistry and Cell Biology
- Publisher
- Canadian Science Publishing
- Published
- 2006-06
- Volume
- 84
- Issue
- 3
- Pages
- 303-311
- ISSN
- 0829-8211 (ISSN-L)
- 1208-6002
- OpenAlex
- W1989873020
- Cited by
- 104
- References
- 83
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 6 · 2023: 6 · 2022: 7 · 2021: 6 · 2020: 5 · 2019: 4 · 2018: 3 · 2017: 3 · 2016: 3 · 2015: 4 · 2014: 7 · 2013: 4 · 2012: 7
- FWCI
- 2.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.nrcresearchpress.com/page/about/CorporateTextAndDataMining (tdm)
- Locations
- Biochemistry and Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
- Keywords
- lactoferrin, Th1/Th2 balance, immune regulation, T cell differentiation, CD4 antigen, Th1 polarization, Th2 polarization, cytokine balance, autoimmune disease, allergic diseases, inflammation, iron binding
- MeSH terms
- Administration, Oral, Animals, Antibodies, Cell Differentiation, Communicable Diseases, Inflammation, Lactoferrin, Mice, Inbred C57BL, Models, Biological, Toxoplasma, Cytokines, Th1 Cells, Th2 Cells, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.